Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis

医学 荟萃分析 内科学 疾病 糖尿病 胆固醇 内分泌学
作者
Alexander Hodkinson,Dialechti Tsimpida,Evangelos Kontopantelis,Martin K. Rutter,Mamas A. Mamas,Maria Panagioti
标识
DOI:10.1136/bmj-2021-067731
摘要

To compare the efficacy of different statin treatments by intensity on levels of non-high density lipoprotein cholesterol (non-HDL-C) for the prevention of cardiovascular disease in people with diabetes.Systematic review and network meta-analysis.Medline, Cochrane Central Register of Controlled Trials, and Embase from inception to 1 December 2021.Randomised controlled trials comparing different types and intensities of statins, including placebo, in adults with type 1 or type 2 diabetes mellitus were included. The primary outcome was changes in levels of non-HDL-C, calculated from measures of total cholesterol and HDL-C. Secondary outcomes were changes in levels of low density lipoprotein cholesterol (LDL-C) and total cholesterol, three point major cardiovascular events (non-fatal stroke, non-fatal myocardial infarction, and death related to cardiovascular disease), and discontinuations because of adverse events. A bayesian network meta-analysis of statin intensity (low, moderate, or high) with random effects evaluated the treatment effect on non-HDL-C by mean differences and 95% credible intervals. Subgroup analysis of patients at greater risk of major cardiovascular events was compared with patients at low or moderate risk. The confidence in network meta-analysis (CINeMA) framework was applied to determine the certainty of evidence.In 42 randomised controlled trials involving 20 193 adults, 11 698 were included in the meta-analysis. Compared with placebo, the greatest reductions in levels of non-HDL-C were seen with rosuvastatin at high (-2.31 mmol/L, 95% credible interval -3.39 to -1.21) and moderate (-2.27, -3.00 to -1.49) intensities, and simvastatin (-2.26, -2.99 to -1.51) and atorvastatin (-2.20, -2.69 to -1.70) at high intensity. Atorvastatin and simvastatin at any intensity and pravastatin at low intensity were also effective in reducing levels of non-HDL-C. In 4670 patients at greater risk of a major cardiovascular events, atorvastatin at high intensity showed the largest reduction in levels of non-HDL-C (-1.98, -4.16 to 0.26, surface under the cumulative ranking curve 64%). Simvastatin (-1.93, -2.63 to -1.21) and rosuvastatin (-1.76, -2.37 to -1.15) at high intensity were the most effective treatment options for reducing LDL-C. Significant reductions in non-fatal myocardial infarction were found for atorvastatin at moderate intensity compared with placebo (relative risk=0.57, confidence interval 0.43 to 0.76, n=4 studies). No significant differences were found for discontinuations, non-fatal stroke, and cardiovascular deaths.This network meta-analysis indicated that rosuvastatin, at moderate and high intensity doses, and simvastatin and atorvastatin, at high intensity doses, were most effective at moderately reducing levels of non-HDL-C in patients with diabetes. Given the potential improvement in accuracy in predicting cardiovascular disease when reduction in levels of non-HDL-C is used as the primary target, these findings provide guidance on which statin types and intensities are most effective by reducing non-HDL-C in patients with diabetes.PROSPERO CRD42021258819.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
优秀的枫发布了新的文献求助10
刚刚
刚刚
KDC完成签到,获得积分10
刚刚
MuMu完成签到,获得积分10
1秒前
1秒前
Yana1311完成签到,获得积分10
2秒前
lkc发布了新的文献求助10
2秒前
大气飞丹完成签到 ,获得积分10
2秒前
调研昵称发布了新的文献求助10
2秒前
yu完成签到 ,获得积分10
3秒前
Lvj发布了新的文献求助10
3秒前
英俊的铭应助lanjq兰坚强采纳,获得10
4秒前
123发布了新的文献求助10
4秒前
含蓄的鹤发布了新的文献求助10
4秒前
4秒前
受伤访波完成签到,获得积分10
5秒前
香蕉觅云应助亻鱼采纳,获得10
5秒前
欢欢发布了新的文献求助10
5秒前
慕青应助研友_Z1WvKL采纳,获得10
5秒前
5秒前
多情怜蕾完成签到,获得积分10
6秒前
6秒前
AD发布了新的文献求助10
7秒前
谢朝邦发布了新的文献求助10
7秒前
科研通AI5应助玲珑油豆腐采纳,获得10
7秒前
7秒前
wjh发布了新的文献求助10
7秒前
Lucky完成签到,获得积分10
8秒前
谨慎涵柏发布了新的文献求助10
8秒前
SciGPT应助心灵美发卡采纳,获得10
8秒前
彩色的蓝天完成签到,获得积分10
8秒前
hbb发布了新的文献求助10
8秒前
3137874883发布了新的文献求助10
10秒前
蒋若风发布了新的文献求助10
10秒前
123完成签到,获得积分10
10秒前
狗剩子完成签到,获得积分10
10秒前
Lvj完成签到,获得积分10
11秒前
bkagyin应助马保国123采纳,获得10
11秒前
11秒前
12秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527699
求助须知:如何正确求助?哪些是违规求助? 3107752
关于积分的说明 9286499
捐赠科研通 2805513
什么是DOI,文献DOI怎么找? 1539954
邀请新用户注册赠送积分活动 716878
科研通“疑难数据库(出版商)”最低求助积分说明 709759